The FDA laid out the qualifications a site would need to qualify for PreCheck on a webpage where companies can also submit ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

The FDA launched PreCheck pilot program to strengthen U.S. drug supply chain by improving regulatory predictability.

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

While there were outliers, Marston said a major chunk of the investments are concentrated in a few key hubs: Pennsylvania and ...

PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...

The pharmaceutical industry relies heavily on its supply chain, but this chain can also have a significant environmental impact due to common factors like high emissions or packaging waste.

In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing ...

XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...

After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to ...